{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:22:08Z","timestamp":1792113728793,"version":"4.4.0"},"reference-count":36,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>We investigated the effect of additional treatment with newer antidiabetic drugs on endothelium function and arterial stiffness in subjects with type 1 diabetes mellitus (T1DM) without cardiovascular diseases. A total of 89 participants, all users of CGMS (continuous monitoring glucose system), were randomized into three comparable groups, receiving empagliflozin (E; n = 30), receiving semaglutide (S; n = 30), and a control group (C; n = 29). At baseline and 12 weeks post treatment, we measured FMD (brachial artery flow-mediated dilation) and FBF (forearm blood flow as reactive hyperemia assessed with strain gauge plethysmography) as parameters of endothelial function, as well as pulse wave velocity (PWV) and peripheral resistance as parameters of arterial stiffness. Improvement in FMD was significant in both intervention groups compared to controls (E group 2.0-fold, p = 0.000 and S group 1.9-fold, p = 0.000), with no changes between those two groups (p = 0.745). During the evaluation of FBF, there were statistically insignificant improvements in both therapeutic groups compared to controls (E group 1.39-fold, p = 0.074 and S group 1.22-fold, p = 0.701). In arterial stiffness parameters, improvements were seen only in the semaglutide group, with a decline in peripheral resistance by 5.1% (p = 0.046). We can conclude that, for arterial stiffness, semaglutide seems better, but both drugs positively impact endothelial function and, thus, could also have a protective role in T1DM.<\/jats:p>","DOI":"10.3390\/pharmaceutics15071945","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T08:35:47Z","timestamp":1689323747000},"page":"1945","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The Effect of Additional Treatment with Empagliflozin or Semaglutide on Endothelial Function and Arterial Stiffness in Subjects with Type 1 Diabetes Mellitus\u2014ENDIS Study"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5629-2646","authenticated-orcid":false,"given":"Maja Prelo\u017enik","family":"Navodnik","sequence":"first","affiliation":[{"name":"Department of Angiology, Endocrinology and Rheumatology, General Hospital Celje, Oblakova ul. 5, 3000 Celje, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6594-5254","authenticated-orcid":false,"given":"Andrej","family":"Jane\u017e","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetes and Metabolic Diseases, University Medical Centre Ljubljana, Zalo\u0161ka Cesta 7, 1000 Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"\u017duran","sequence":"additional","affiliation":[{"name":"Department of Angiology, Endocrinology and Rheumatology, General Hospital Celje, Oblakova ul. 5, 3000 Celje, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"EMPA REG outcome","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_2","first-page":"347","article-title":"Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes","volume":"24","author":"Stephen","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"LEADER: Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"SUSTAIN 6: Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_5","first-page":"773","article-title":"Management of hyperglycaemia in type 2 diabetes. A consensus report by the American Diabetes","volume":"10","author":"Davies","year":"2019","journal-title":"Diabetes Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa1408214","article-title":"Glycemic control and excess mortality in type 1 diabetes","volume":"371","author":"Lind","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s13300-019-0612-8","article-title":"Cardiovascular Risk in Type 1 Diabetes Mellitus","volume":"3","author":"Schofield","year":"2019","journal-title":"Diabetes Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial Function and Dysfunction Testing and Clinical Relevance","volume":"115","author":"Deanfield","year":"2007","journal-title":"Circulation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1177\/1741826711398179","article-title":"Methods for evaluating endothelial function: A position statement from the European Society of Cardiology Working Group on Peripheral Circulation","volume":"6","author":"Lekakis","year":"2011","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0735-1097(03)00994-X","article-title":"The clinical implications of endothelial dysfunction","volume":"42","author":"Widlansky","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/1479164117748840","article-title":"Regional arterial stiffness in central and peripheral arteries is differentially related to endothelial dysfunction assessed by brachial flow-mediated dilation in metabolic syndrome","volume":"2","author":"Badhwar","year":"2018","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","article-title":"International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force","volume":"39","author":"Corretti","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1536\/ihj.14-385","article-title":"Assessment of endothelial function. History, methodological aspects, and clinical perspectives","volume":"56","author":"Higashi","year":"2015","journal-title":"Int. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1152\/ajpregu.00339.2019","article-title":"Reactive hyperemia: A review of methods, mechanisms, and considerations","volume":"318","author":"Rosenberry","year":"2020","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1751-7176.2008.04746.x","article-title":"Effects of arterial stiffness, pulse wave velocity, and wave reflections on the central aortic pressure waveform","volume":"10","author":"Nichols","year":"2008","journal-title":"J. Clin. Hypertens."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1210\/jc.2010-2363","article-title":"Endothelial dysfunction is related to poor glycemic control in adolescents with type 1 diabetes under 5 years of disease: Evidence of metabolic memory","volume":"96","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3389\/fendo.2020.00203","article-title":"Early Endothelial Dysfunction in Type 1 Diabetes Is Accompanied by an Impairment of Vascular Smooth Muscle Function: A Meta-Analysis","volume":"11","author":"Lespagnol","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref_19","first-page":"876547","article-title":"Effects of Glucose Control and Variability on Endothelial Function and Repair in Adolescents with Type 1 Diabetes","volume":"2013","author":"Hoffman","year":"2013","journal-title":"Int. Sch. Res. Not."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2337\/dc17-1600","article-title":"International Consensus on Use of Continuous Glucose Monitoring","volume":"40","author":"Danne","year":"2017","journal-title":"Diabetes Care"},{"key":"ref_21","first-page":"4385312","article-title":"Impact of Real-Time Continuous Glucose Monitoring Use on Glucose Variability and Endothelial Function in Adolescents with Type 1 Diabetes: New Technology\u2014New Possibility to Decrease Cardiovascular Risk?","volume":"2016","author":"Luczynski","year":"2016","journal-title":"J. Diabetes Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10557-007-6041-3","article-title":"ACE inhibition and endothelial function: Main findings of PERFECT, a sub-study of the EUROPA trial","volume":"21","author":"Bots","year":"2007","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.atherosclerosis.2012.01.031","article-title":"Meta-analysis of the effects of statin therapy on endothelial function in patients with diabetes mellitus","volume":"223","author":"Zhang","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12933-019-0839-8","article-title":"How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial","volume":"18","author":"Bosch","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/CIRCULATIONAHA.117.029529","article-title":"Effects of the selective sodium-glucose cotransporter 2 inhibitor empagliflozin on vascular function and central hemodynamics in patients with type 2 diabetes mellitus","volume":"136","author":"Striepe","year":"2017","journal-title":"Circulation"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1232583","DOI":"10.1155\/2018\/1232583","article-title":"Effects of Newer Antidiabetic Drugs on Endothelial Function and Arterial Stiffness: A Systematic Review and Meta-Analysis","volume":"2018","author":"Batzias","year":"2018","journal-title":"J. Diabetes Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12933-018-0797-6","article-title":"Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus","volume":"17","author":"Lunder","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/dom.12041","article-title":"Metformin improves endothelial function in type 1 diabetic subjects: A pilot, placebo-controlled randomized study","volume":"15","author":"Pitocco","year":"2013","journal-title":"Diabetes Obes. Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12933-017-0621-8","article-title":"Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: A pilot study","volume":"16","author":"Solini","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12933-017-0646-z","article-title":"Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes","volume":"17","author":"Lambadiari","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_31","unstructured":"Delong, C., and Sharma, S. (2023, May 22). Physiology, Peripheral Vascular Resistance. StatPearls Publishing, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538308\/."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1479164119883540","DOI":"10.1177\/1479164119883540","article-title":"Effect of empagliflozin on brachial artery shear stress and endothelial function in subjects with type 2 diabetes: Results from an exploratory study","volume":"17","author":"Irace","year":"2020","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"826604","DOI":"10.3389\/fendo.2022.826604","article-title":"Effects of SGLT-2 Inhibitors on Vascular Endothelial Function and Arterial Stiffness in Subjects with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Endocrinol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3803\/EnM.2016.31.1.80","article-title":"Effects of short-term exenatide treatment on regional fat distribution, glycated hemoglobin levels, and aortic pulse wave velocity of obese type 2 diabetes mellitus patients","volume":"31","author":"Hong","year":"2016","journal-title":"Endocrinol. Metab."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Maruhashi, T., and Higashi, Y. (2021). Pathophysiological Association between Diabetes Mellitus and Endothelial Dysfunction. Antioxidants, 10.","DOI":"10.3390\/antiox10081306"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jss.2008.04.026","article-title":"Autoimmune-mediated oxidative stress and endothelial dysfunction: Implications of accelerated vascular injury in type I diabetes","volume":"155","author":"Zimmerman","year":"2009","journal-title":"J. Surg. Res."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/15\/7\/1945\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:11:56Z","timestamp":1760127116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/15\/7\/1945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["pharmaceutics15071945"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics15071945","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,14]]}}}